Research Letter
IVF & Reproductive Biology Centre, Department of Obstetrics and Gynecology, Maulana Azad Medical College, New Delhi, India
Department of Obstetrics and Gynecology, Maulana Azad Medical College, New Delhi, India
c
Department of Obstetrics and Gynecology, Vardhaman Mahavir Medical College, New Delhi, India
b
a r t i c l e i n f o
Article history:
Accepted 14 August 2014
* Corresponding author. Dr. Sudha Prasad, IVF & Reproductive Biology Centre,
Maulana Azad Medical College, 2-Bahadur Shah Jafar Marg, New Delhi 110002,
India.
E-mail address: drsprasad@yahoo.com (S. Prasad).
http://dx.doi.org/10.1016/j.tjog.2014.08.005
1028-4559/Copyright 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
sperm quality at the time of oocyte retrieval, or low or no fertilization in previous cycles. Fertilization rate was dened as the ratio
of zygotes with two pronuclei observed 18e22 hours after insemination to the number of oocytes inseminated. Embryos were
scored using a classication system comprising cleavage stage,
variation of blastomere size, shape, fragmentation, and also multinucleation. Embryos were classied into four classes, from class 1
(high quality) to class 4 (low quality); class 4 embryos were not
transferred. After 3e5 days of oocyte retrieval, a maximum of two
to three high-quality embryos were transferred under ultrasound
guidance. Luteal support was provided in all patients with progesterone (50 mg, intramuscularly) in oil on alternate days and
micronized progesterone vaginal capsules 800 mg (Cap. Susten;
Sun Pharmaceutical Ind. Ltd., Halol, Baroda, Gujrat, India) daily in
two divided doses for the next 14 days after embryo transfer procedure. For conrmation of pregnancy, a urine pregnancy test was
conducted and serum beta human chorionic gonadotropin levels
were estimated on the 14th day.
Patient characteristics and ovarian stimulation parameters are
shown in Table 1. Women in the two groups (endometriosis-related
infertility and tubal factor groups) were comparable in terms of age,
body mass index, Day 3 FSH level, Day 3 antral follicle count, and
the FSH to luteinizing hormone (LH) ratio.
It was observed that the patients in the tubal factor group used a
lesser amount of gonadotropins, but duration of the stimulation was
comparable. This group further attained higher peak E2 (estradiol)
and P4 (progesterone) levels than women with endometriosis.
However, the progesterone to estradiol ratio was higher in the
endometriosis group than in the tubal group. The endometrial
thickness on the day of trigger, and the number of follicles > 15 mm
in size and their subsequent fertilization percentage as depicted by
the two pronuclear stages were signicantly higher in women with
tubal factor as compared to those with endometriosis. However,
even though the pregnancy rate in both groups was almost the
same. The pregnancy rate in the tubal factor group was 32.2% (10/
31) as compared to 29.8% (9/31) in the endometriotic group.
The main ndings of our study was that women with Stage I
endometriosis and those with Stages IIeIV post GnRH-a depot
administration had comparable pregnancy rates in fresh embryo
Table 1
Comparison between endometriosis-related infertility and tubal factor groups.
Parameters
Endometriosis
(mean SD)
Tubal
(mean SD)
No. of patients
Age
Duration of infertility
BMI
Recombinant
gonadotropins (IU)
hMG (IU)
Days of stimulation
Day 3 AFC
FSH
FSH to LH ratio
Total no. of oocytes
E2 levels on the day of
trigger
P4 levels on the day of
trigger
P4 to E2 ratio
ET (on trigger day)
Fertilization rate
Fertilization percentage
Clinical pregnancy (%)
31
30.44 0.663
6.19 3.820
24.63 3.213
1796.09 184.71
31
30.10 0.543
6.63 2.48
23.85 3.081
1563.71 188.04
0.171
0.483
0.986
0.425
183.02 157.15
9.28 3.185
8.75 0.774
6.23 2.081
1.92 1.493
7.59 4.8
1810.46 1688.84
1447 234.62
10.9 0.312
8.10 0.515
6.234 2.0810
1.83 1.73
11.23 8.31
2078.44 1605.18
0.03
0.023
0.049
0.489
0.423
0.022
0.957
1.07 1.122
1.39 1.39
0.206
4.09 5.023
9.44
50.9 0.620
66.71 2.37
25.8
1.87 5.33
10.14
78.7 0.920
80.84 6.83
29.03
0.068
0.008
0.105
0.009
0.289
AFC antral follicle count; BMI body mass index; ET endometrial thickness;
FSH follicle-stimulating hormone; hMG human menopausal gonadotropin;
LH luteinizing hormone; SD standard deviation.
317
318
[7] Abuelghar WM, Elsaeed MM, Tamara TF, Ellaithy MI, Ali MS. Measurement of
serum estradiol/progesterone ratio on the day of embryo transfer to predict
clinical pregnancies in intracytoplasmic sperm injection (ICSI) cycles. Is this of
real clinical value? Middle East Fertil Soc J 2013;18:31e7.
[8] Chedid S, Camus M, Smitz J, Van Steirteghem AC, Devroey P. Comparison
among different ovarian stimulation regimens for assisted procreation procedures in patients with endometriosis. Hum Reprod 1995;10:2406e11.
[9] Gomez-Torres MJ, Acien P, Campos A, Velasco I. Embryotoxicity of peritoneal
uid in women with endometriosis. Its relation with cytokines and lymphocyte populations. Hum Reprod 2002;17:777e81.
[10] Wunder DM, Mueller MD, Birkhauser MH, Bersinger NA. Increased ENA-78 in
the follicular uid of patients with endometriosis. Acta Obstet Gynecol Scand
2006;85:336e42.